Neonatal screening for congenital hypothyroidism: a retrospective hospital based study from Bahrain

Jamal Golbahar1, Haya Al-Khayyat, Babiker Hassan

  • 1Al-Jawhara Centre for Neonatal Screening and Genetic Diagnosis and Research, College of Medicine and Medical Sciences, AGU, Manama, Kingdom of Bahrain. jamalgo@agu.edu.bh

Insights

Congenital hypothyroidism (CH) screening in Bahrain revealed a high incidence of 1:2,967 births for permanent CH. This highlights the need for a national newborn screening program to detect this endocrine disorder early.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Public Health

Background:

  • Neonatal screening for congenital hypothyroidism (CH) is standard in developed nations.
  • Congenital hypothyroidism is a significant endocrine disorder affecting newborns.

Purpose of the Study:

  • To evaluate the incidence of CH in Bahrain using cord blood thyroid-stimulating hormone (TSH).
  • To assess the effectiveness of current screening methods in a specific hospital setting.

Main Methods:

  • Recalled neonates with cord blood TSH >25 mU/l for further testing.
  • Diagnosed permanent CH based on elevated TSH (> or =15 mU/l) and low free T4 (<12 pmol/l) in venous blood, alongside abnormal thyroid scans.

Main Results:

  • Identified 23 cases of transient TSH elevation (1:774 births).
  • Diagnosed 6 cases of permanent CH (1:2,967 births), with equal male and female incidence.
  • 714 newborns were recalled for further evaluation.

Conclusions:

  • The study indicates a high incidence of CH in Bahrain.
  • Recommends establishing a national screening program for CH in the Kingdom of Bahrain.
  • Early detection and management of congenital hypothyroidism are crucial for infant health.
Abstract